Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise as nonsteroidal treatments for hair loss.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

The availability of certain hormones and specific stimulation patterns affect long-term synaptic changes in the male rat brain.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

L-PRF is effective for bone regeneration in the mouth.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

PDRN from trout sperm helps skin and hair regeneration but is costly and complex to produce.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

The compounds tested could potentially treat hair loss and alopecia.

Injectable biostimulators can improve skin by boosting collagen and fat cell activity, but more research is needed to confirm their safety and effectiveness.

LLPS is crucial for RALF signaling, aiding plant growth and stress resilience.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

A new model helps predict treatment success in girls with early puberty.

Mutations in certain receptors can cause diseases and offer new treatment options.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Neurosteroids may help treat disorders with too much dopamine activity.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.